Elanco

Ellevest Inc. raised its stake in shares of Elanco Animal Health by 38.0% during the 1st quarter.

Elanco Animal Health stock opened at $15.89 on Friday.

Elanco Animal Health stock opened at $16.25 on Friday.

Elanco's aquaculture assets include a fish health vaccine lab in Charlottetown's West Royalty Industrial Park that employs 140 people.

Raymond James & Associates grew its position in shares of Elanco Animal Health by 19.6% in the 4th quarter.

Stifel Nicolaus reaffirmed a “buy” rating and issued a $20.00 price objective on shares of Elanco Animal Health in a research report on Thursday, September 19th.

Thrivent Financial for Lutherans lessened its stake in Elanco Animal Health Incorporated () by 0.2% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission.

Elanco Animal Health had a positive return on equity of 4.83% and a negative net margin of 3.63%.

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for companion and food animals.

Elanco Animal Health Incorporated is based in Greenfield, United States.

In the Matter of Elanco Animal Health, Incorporated, a corporation; and Bayer Aktiengesellschaft, a corporation.

The major players covered in the veterinary medicine market report are Merck & Co., Inc., Ceva, Vetoquinol S.A., Zoetis, BoehringerIngelheim International GmbH, Bayer AG, Elanco.

Aaron Schacht, Elanco’s head of research and development, said those alternatives could include enhancing the animals’ own immune function, immunizing against particular pathogens or reshaping their gut bacteria to favor the good ones.

Citizens Financial Group Inc RI boosted its stake in Elanco Animal Health by 26.5% in the 2nd quarter.

Elanco Animal Health (NASDAQ:ELAN) last issued its earnings results on Tuesday, August 13th.

Elanco Animal Health’s product in the chewables category, Interceptor Plus, which controls heartworm in dogs, raked $100 million in sales last year.

Elanco is joining critical conversations about food and nutrition security, human emotional and physical well-being and the sustainability of the planet, and sharing the importance of helping animals lead healthier lives.

FTB Advisors Inc. purchased a new stake in shares of Elanco Animal Health during the first quarter valued at $29,000.

Heritage Investors Management Corp owned approximately 0.06% of Elanco Animal Health as of its most recent SEC filing.

Mr. Simmons said that while Elanco “started as an antibiotic company,” antibiotics that are medically important for people and used in livestock feed now make up only 5 percent of its sales.